Literature DB >> 7053760

Antibody-dependent cytolysis of the human leukemia cell line K-562 in the absence of effector cells or complement.

C J Wust, M Green, C B Lozzio, B B Lozzio.   

Abstract

K-562 human leukemia cells grown in the presence of specific goat anti-K-562 gamma globulin, F(ab)'2, Fab', or Fab showed a decrease in DNA and protein syntheses and a loss of cell viability within several hours. Eventually all cells died and lysed within 2-5 days. These events occurred in the absence of added effector cells or complement. The effect on the cell was not due to proteolytic or other external lytic activity generated at the cell surface, since 51Cr-labeled bystander cells or antibody-sensitized bystander cells (chicken erythrocytes or K-562 cells) were not lysed when added to cultures of K-562 cells incubated with immune globulin. The anti-K-562 gamma globulin was not observed to patch or cap on K-562 cells, but the ability of bound immunoglobulin to fix complement decreased markedly (50% in 60 min), so that no complement-mediated cytolysis could be observed at 2 hr. However, the immunoglobulin, at least portions of it, reacted with fluorescein--labeled rabbit anti-goat gamma globulin for about 16 hr. 125I-labeled immune globulin appeared to be internalized and released into the medium as small degradation products. 125I-labeled Fab did not appear to be internalized, since it was released intact and more rapidly from cells than the intact globulin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7053760

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  3 in total

1.  Characterization of the Fc(IgG) receptor on the pluripotential leukaemia cell K-562.

Authors:  A T Ichiki; C J Wust; C B Lozzio
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

2.  Relationship between the Fc receptor for IgG and the specific associated antigen of the pluripotential leukaemia cell line, K-562.

Authors:  A T Ichiki; B B Lozzio; C J Wust; C B Lozzio
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

3.  Immunotherapy of human leukemia with antibody to pluripotential K-562 stem cells.

Authors:  J Izquierdo; E R Robbio; B B Lozzio; W Hanna
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.